Article from Scientific American Supports Tau Protein as Key Player in Treatments for Neurodegeneration
The protein, once seen as a secondary player, has taken a leading role in combating neurodegenerative illnesses
Kingston — Thursday April 16th, 2020 — An article published in the Scientific American on March 2nd references years of research on the irregular buildup of the beta-amyloid and tau proteins in the brain leading to Alzheimer’s disease.
A lack of success studying the impact of beta-amyloid has now led to a shift in focus on tau.
New perspectives and additional efforts focused on the tau protein is welcome news to those involved in developing medicine for rare illnesses like PSP where toxic tau is a focal point of research.
Author: Karen Weintraub is a freelance health and science journalist who writes regularly for the New York Times, STAT and USA Today, among others.